Mike Luby
Founder & CEO
Mike Luby is the Founder of Fonseca Biosciences, LLC and serves as our President & CEO. Mike has worked in pharmaceutical marketing and sales since 1990, and began his journey as an entrepreneur in 2000.
In addition to his role at Fonseca Biosciences, Mike is currently the Founder and CEO of HCP Concierge and BioPharma Alliance. Previously, he co-founded TargetRx, a leading pharmaceutical database and analytics company focused on helping pharmaceutical companies understand the drivers of their sales and marketing efforts. During his ten years at TargetRx, the Company succeeded in raising over $50 million in capital, securing clients in the majority of the top 30 pharmaceutical companies worldwide and delivering over $120 million in revenue on a cumulative basis. Mike is the lead author on TargetRx’s patented method of analyzing the effectiveness of marketing strategies. Mike has been honored with the Philadelphia Business Journal’s “40 Under 40” award and selected by PharmaVOICE as one of the “100 most inspiring people in life sciences.” Under his leadership, TargetRx was recognized by the Eastern Technology Council with the Enterprise Award for “Growth Company of the Year.”
Prior to his career as an entrepreneur, Mike spent 10 years at Merck & Co., Inc., where he created and executed marketing strategies for both specialty and mass-market drugs. As head of worldwide marketing for 2 late stage, pre-launch products at Merck, Mike spearheaded global strategy and launch planning. He also served as director of new product marketing, managing the marketing strategy of early-stage drug development candidates and evaluating the potential of in-licensing opportunities from biotech companies. Mike’s previous roles included senior marketing manager for Fosamax, marketing analyst for Vasotec and Prilosec, as well as positions focusing on marketing to managed care customers in an assignment at Merck-Medco Managed Care. Mike began his career at Merck in sales.
Mike holds a B.A. in economics from Dartmouth College and an M.B.A. from the Wharton School of the University of Pennsylvania.